title: Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium.
authors.affiliation: IMS Health HEOR, Vilvoorde, Belgium.
authors.forename: M
authors.initials: M
authors.lastname: Lamotte
authors.affiliation: IMS Health HEOR, Vilvoorde, Belgium.
authors.forename: L
authors.initials: L
authors.lastname: Gerlier
authors.affiliation: IMS Health HEOR, Vilvoorde, Belgium.
authors.forename: K
authors.initials: K
authors.lastname: Caekelbergh
authors.affiliation: Cardiome Pharma Corp, Vancouver, BC, Canada.
authors.forename: K
authors.initials: K
authors.lastname: Lalji
authors.affiliation: Cardiome Pharma Corp, Vancouver, BC, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Polifka
authors.affiliation: Cardiome Pharma Corp, Vancouver, BC, Canada.
authors.forename: E
authors.initials: E
authors.lastname: Lee